Table 2 Comparison of the adverse reactions [cases (%)]
From: Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients
Group | Leukopenia reduction | Hemoglobin reduction | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | Grade 0 | Grade I | Grade II | Grade III | Grade IV | Grade 0 | Grade I | Grade II | Grade III | Grade IV |
The control group (n = 78) | 4 (58.97) | 15 (19.23) | 15 (19.23) | 2 (2.56) | 0 (0.00) | 46 (58.97) | 20 (25.64) | 12 (15.38) | 0 (0.00) | 0 (0.00) |
The observation group (n = 80) | 62 (77.50) | 16 (20.00) | 2 (2.50) | 0 (0.00) | 0 (0.00) | 65 (81.25) | 12 (15.00) | 8 (10.00) | 0 (0.00) | 0 (0.00) |
x2 value | 14.321 | 10.629 | ||||||||
P value | 0.002 | 0.005 | ||||||||